Dr. McNatty is an assistant professor of pharmacy practice at Midwestern University College of Pharmacy, Glendale, Arizona.
Nausea is one of the most common medication side effects that patients report, as virtually all agents have the ability to cause stomach disturbances. Nausea can range from a slight annoyance to a debilitating condition causing disruption to a patient's daily life.
Medication-related nausea can have a profound impact on patient outcomes because nonadherence to prescribed therapy can lead to treatment failure. A loss of appetite may occur, which can lead to poor nutrition. Nausea also can have psychological effects on patients, and they may become apprehensive about taking medications in the future. Patient education by pharmacists and other health care professionals can reduce substantially the likelihood of nausea as a side effect and help patients achieve optimum benefit from medication therapy.
Chemotherapy-induced nausea is the most studied type of medication-related nausea. Nausea and vomiting due to chemotherapy is a very common and debilitating event for patients undergoing this treatment, and guidelines written specifically for this side effect have been developed.1,2
Nausea and vomiting can cause dehydration, malnourishment, increased anxiety, and stress in a patient population already at high risk for medication-related complications. Nausea and vomiting are categorized as acute, delayed, anticipatory, breakthrough, and refractory; in the ambulatory care setting, delayed and anticipatory nausea are seen frequently.
When a patient who is not receiving chemotherapy presents with nausea, it is often difficult to determine the cause. In addition to medications, other causes (eg, migraine, emotional response, pregnancy, and gastrointestinal disorders) must be considered.
Nausea caused by medications is typically acute rather than chronic and usually is seen shortly after starting a medication.3 Medications can cause nausea via several mechanisms. Dopaminergic agonists, nicotine, digoxin, and opiates have been shown to act on the area postrema. Some agents (eg, nonsteroidal anti-inflammatory drugs [NSAIDs] and erythromycin) activate peripheral afferent pathways, stimulating the brainstem nuclei.3 Nausea also can be induced through stimulation and activation of the chemoreceptor trigger zone (CTZ). Stimuli cause the CTZ to recognize a substance as foreign and activate the vomiting center.
The most common substances to cause stimulation are chemotherapy drugs, opiates, and ipecac syrup. Many other drugs (eg, antibiotics, NSAIDs, selective serotonin reuptake inhibitors [SSRIs], and digoxin) also can cause the activation of the CTZ.4 The mechanism associated with a number of medication classes known to cause nausea remains unclear. Some of these include anti-arrhythmics, antihypertensives, diuretics, oral hypoglycemics, and oral contraceptives.3
Preventing nausea caused by medication often can be achieved with a few simple reminders. Unless an agent is meant to be taken on an empty stomach, patients can be advised to take their medications with food. This is an easy way to prevent nausea, especially with notorious offenders, such as antibiotics, NSAIDS, and multivitamins. The time of day a medication is taken may be an important consideration when preventing nausea caused by dizziness. Taking medications such as SSRIs at bedtime prevents the vomiting center from being activated by dizziness because the body is asleep.4
o n l i n e
A complete discussion of treatment guidelines for chemotherapy-related nausea can be accessed at www.nccn.org/patients/patient_gls.asp.
If these simple interventions are not effective, the next step is to identify any alternative agents that can be used to provide equal efficacy with less nausea for the patient. If the nausea is being caused by any of the excipients, a simple formulation switch may help. The patient can try either the same product from a different manufacturer or change formulations—from a tablet to a liquid, for example. If this is not possible or does not work, changing to an alternative agent with the same mechanism of action may alleviate the nausea. Finally, if this option is not possible or proves to be ineffective, changing to a medication with an entirely different mechanism of action may be warranted. These nonpharmacologic interventions are summarized in the Figure.
When nonpharmacologic recommendations do not work, patients can turn to pharmacologic agents to prevent and/or treat nausea caused by medication use. Dopamine antagonists, such as promethazine and prochlorperazine, are especially effective for opioid-induced nausea, but can be beneficial for nausea caused by other medications as well. They are a good choice for short-term offenders, such as antibiotics and NSAIDS. Long-term use may be limited by extrapyrimidal side effects. The use of serotonin receptor antagonists (eg, ondansetron and granisetron) may be beneficial for long-term prevention of nausea. The use of this class of agents is often limited by cost to the patient.
Many patients consider nausea to be a sign of an allergic reaction. This can have profound effects on future therapy. If an allergy is documented in a patient's profile, it could lead to the choice of a less-than-optimal agent for future treatment.
Pharmacists can play a key role in making sure every patient understands the difference between an allergic reaction and an adverse reaction. An ideal time to do this is during the initial contact with the patient while getting a medication history. Verifying allergies and the specific reaction caused by the offending agents is the first step in identifying misinterpreted reactions. In addition, health care professionals should be vigilant about documenting new allergies/intolerances and counseling patients appropriately about these issues.
Nausea is a common medication-related side effect with many potential causes. Nausea can have a significant impact on a patient's physical and psychological health. Proper counseling on prevention and treatment of nausea due to medication use can help patients better understand how to take their medications for optimum benefit with minimal side effects.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs